X-Mozilla-Status: 0000
X-Mozilla-Status2: 00000000
X-Apparently-To: jeeproject@yahoo.com via 72.30.238.180; Wed, 04 Dec 2013 09:30:02 -0800
Return-Path: <info@updates.f1000.com>
Received-SPF: pass (domain of updates.f1000.com designates 81.92.113.151 as permitted sender)
X-YMailISG: 0M1mC_MWLDvx97M2IMYuw7tJ5x4TJtdOR1_ijDz.TCiYpKe8
 9i1eyAs2P4tiZDi4F9i5DPTkdNV7VSdCSJHFsuweO.frtJ9emzbVfaT7Gtb1
 nShIZOVwIgN2PWF2y3vIsyNegSux_NGC3KdeYTN_Ce_awBuCHrMoy9a.zNnw
 yHKTRbFquBwf0NZSLzcsyMLVKM3iapUvmJk94nAejE.92hL0dFln1iY.dBtM
 83K9LY1V6EdHcuIIsxtDBIh4StbOmF6jITivs4uEkD7dGKIve1PWq2yThvfE
 EltW5FfYs5_.S0Zare_gT_BxY99MOdA1Tk5pOc3EvSnP_ayCZAqcSglvmGOK
 uDAKtxMSDeliN1IAyI1u8ogYavGOtuvp__n8V_vUYkEDERlIN9zYEjWTaPL1
 hsUh5SGJpADbI7ayww0hZ2V4IhanEzL7f6O_OcKxJ0EUN71W_hWNbZVk5Aya
 WTBLiNZy058THIdwqfGWVFINZnaouHEn2tPM48WGQiBE96cZGK3qPw.UVHYv
 cUkF6crAP4bO0i04.Ar5LVY7ZuGkxeAC8D275PPx.vYPjXSTZBMXglXxnRNw
 beEH.gYgTIZGCsRsvmKcEI37Jz3fxC2AjIDDUc3WLsLklnBOZoLozQEUz7Ni
 V9egXsxuNfoPITRUh7OVOpQmMrj5lhpHGGgxo2DZbi63rXSxkC9__XEKYsTC
 XLGi3nYNEMpPo.iEwaDruNxIlw_kA_ykbFgkuj9uPUcyvU2HEegjXf1ZTNEM
 5XQWHK5LTAzXj4CusAdrGhoGHxv0ID3lJWaXE81hpGAkXuC3c5UjF0xt3YAw
 2jO2HdKCKZ2Ki0f.P03RGywKc5RTiiOhs5lRGCGFBEkorNqoyqvSp7ywi8iE
 4ewoUBnTISsYmLr_gP6hULK1NqkXLIzj0536F16WF43_ykRVOb7zIXvYETMZ
 ge5FU.yK68cCVwtIV1uJm_Km.VxA7OPfW9KYqtzL0nKys4v4D2b.1xhFLKvR
 hIJdB5sJ69Y5rKC2YB1xQmOGZerEJE7XNA4y3_3YxeAvD1r563JyrwQTSHPU
 Fq9QvPzX9HUmO62EiDEqq5YYi3RIqH6jtfaKrFjWN_YAlavHvHagw8Fa76yC
 NpXW_4PO_bWDyE.pswmFV8gRDzJ1tDK4DL14ZpiviUiypUSC0tfCKT.2uMlW
 ExCzjoBk.u.eMxPC74VxP.SQtrNMm_Y9Ur7hvNnooH.WCfU3oaMrg4FcPGu.
 SXpdwyA6IDYAQifygiA3YzS2MpQFX2d1LsKBW8kAlLa_cYvvFyMTVhGa49EX
 TqMk7FuwbpsjYDKMoGK2IV7PY2tynp.BUe5WMAF_PBvRTT0MJXI4i6rNekK1
 tbEDWCItGfdMYPosu3IIXT0TCwftXCrorBhXEWMXbQeDcGsT5jX9aSBDg03B
 wNNxof1ccxkUlmtH_.mkQ7j0jvJKvujNL0sWzi1Sg69.qp2Ue7BXYy4BpVPT
 iEOyLlsmf0pKDMb3mCJZGVA_bY_RRFzbYam8LKY0tt4Xxi.4exyX_6a_zCDi
 BOCLx0B9QbYQS8Ndfc1y394mbsEP_0ugKGxFVgJ.DloC74MjmBn97jiMeW52
 TZkVHgg_IL8U1yETELWLEumdazeFbhriNRSMuqrPHLmpG1KiDH39m.e9letR
X-Originating-IP: [81.92.113.151]
Authentication-Results: mta1133.mail.bf1.yahoo.com  from=updates.f1000.com; domainkeys=neutral (no sig);  from=updates.f1000.com; dkim=pass (ok)
Received: from 127.0.0.1  (EHLO emailer113-151.emv5.com) (81.92.113.151)
  by mta1133.mail.bf1.yahoo.com with SMTP; Wed, 04 Dec 2013 09:30:02 -0800
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=emv; d=updates.f1000.com;
 h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type:List-Unsubscribe; i=info@updates.f1000.com;
 bh=wkpRER+Sr+uoNmkvuOKcD0XSF0k=;
 b=JJgmJcHr36qJ/lIKdSjZNm6wOFuabs2dTXEHXGQm8xFZiKym2I0owE54ismOJJ6w4DdqUsYULm2m
   kUy8S6u7Eyrvwmf6XqNMeBb2e9cVBxrSJdImqZ8roMcWsEpxKdZZMRB37nKDSMIJUsr34emmATSZ
   Tvkr4zoECkKhev3vr34=
Received: by emailer113-151.emv5.com id hjtj9i16758q for <jeeproject@yahoo.com>; Wed, 4 Dec 2013 18:26:34 +0100 (envelope-from <info@updates.f1000.com>)
Return-Path: info@updates.f1000.com
Date: Wed, 4 Dec 2013 18:26:34 +0100 (CET)
From: Faculty of 1000 <info@updates.f1000.com>
Reply-To: Faculty of 1000 <info@f1000.com>
To:  <jeeproject@yahoo.com>
Message-ID: <2.1.4.1101019921.2385251.807521937@updates.f1000.com>
Subject: Season's greetings! Festive picks from F1000
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary=2385251807521937
X-EMV-Platform: p4ccc.campaigncommander.com$
X-EMV-CampagneId: 2385251$
X-EMV-MemberId: 807521937$
List-Unsubscribe: <http://p4trc.emv2.com/HD?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMe1PcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlH0>, <mailto:unsubscribe@updates.f1000.com?subject=unsubscribe-4-ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMe1PcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlH0>
Content-Length: 72230

--2385251807521937
Content-Type: text/plain; charset=iso-8859-15
Content-Transfer-Encoding: 8bit

To ensure you receive emails from Faculty of 1000, add info@updates.f1000.com to your safelist.

-----------------------------------------------------

Faculty of 1000 |  http://f1000.com                
Monthly Update  |  December 2013         

-----------------------------------------------------
 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
  Season's greetings and best wishes        
  for the New Year from everybody at Faculty of 1000!    
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 Highly influential scientists amongst F1000 Faculty    
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Using citation data collected from 1996-2011, authors writing in the European Journal of Investigation last month published a list of 539 influential biomedical researchers, of which 59 are F1000Prime Faculty Members [ http://blog.f1000.com/2013/11/11/f1000prime-faculty-members-among-highly-influential-biomedical-researchers/ ]. 

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 F1000Prime partnership in bioinformatics     
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Members of the International Society for Computational Biology can now receive full access to F1000Prime until 30 April 2014 [ http://f1000.com/prime/iscb ] as part of their society membership. And -- a list of the latest recommended articles in F1000Prime's Bioinformatics and Computational Biology Faculty is freely available in Mendeley [ http://blog.f1000.com/2013/10/30/mendeley-and-a-microcosmic-narrative/ ]. 


   F1000Prime                             
==================

1,328 recommendations [ http://f1000.com/prime/search/evaluations ] added in the past month. Below is a selection:   

Back to full potential    
[ http://f1000.com/prime/718113987?key=QnjYjslm4YKoNMr ]   
This paper provides a loophole to the stochastic nature of reprogramming, allowing somatic cells to be reverted back into pluripotent stem cells.   
Rais Y, Zviran A, Geula S et al.    
Nature. 2013 Oct 3; 502:65-70

Decoding asthma    
[ http://f1000.com/prime/718097799?key=KwY5rzjd4DU1mFq ]   
This study on asthma polymorphisms demonstrates a broad approach with which to bridge the gap between genetic association at the population level and molecular cell mechanisms.
Ho JE, Chen WY, Chen MH et al.   
J Clin Invest. 2013 Oct 1; 123:4208-18

Significant stats    
[ http://f1000.com/prime/718170771?key=GqPGUd2xQAJqOLD ]   
Too often scientists try to find a statistical significance test "validating" their hypothesis after the experiment, which may be a reason why so many studies are irreproducible.   
Johnson VE. Proc Natl Acad Sci U S A. 2013; 110:19313-7   

* F1000Prime Reports *

Open-access review journal [ http://f1000.com/prime/reports/ ], reporting on the hottest topics.

New and alternative approaches to tackling antibiotic resistance    
[ http://f1000.com/prime/reports/b/5/51/ ]   
Multi-drug-resistant bacteria are fast overcoming our current arsenal of antibiotics, thanks to our complacency, but recent advances in thwarting their resistance mechanisms give us cause for hope.
F1000Prime Report by Theriault N and Tillotson GS [ http://f1000.com/prime/thefaculty/member/6565473182507832 ].
F1000Prime Rep 2013, 5:51

 ---------------
 See all recent F1000Prime Reports          
 >> http://f1000.com/prime/reports/                 
 ---------------   
    
  
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 F1000Prime: Live online demo 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 
Get the most out of F1000Prime - attend a live online demonstration.

Please choose one of the following time zones:

 ---------------------------
 > > The Americas: http://f1000-demo-americas.eventbrite.co.uk/    
 > > Europe & Asia: http://f1000-demo-eu-asia.eventbrite.co.uk/   
 ---------------------------



   F1000Research                      
======================

Our innovative open access journal [ http://f1000research.com/ ] offering rapid publication, open peer review and open data.

Below is a selection of our latest peer reviewed articles:  

RESEARCH ARTICLE
Homologous electron transport components fail to increase fatty acid hydroxylation in transgenic Arabidopsis thaliana [ http://f1000research.com/articles/2-203/v2 ] [v2; ref status: indexed, http://f1000r.es/2a3 ]
Latest Published: 13 Nov 2013   
Wayne LL, Browse J.   
F1000Research 2:203   

CORRESPONDENCE
Issues with data transformation in genome-wide association studies for phenotypic variability [ http://f1000research.com/articles/2-200/v1 ] [v1; ref status: indexed, http://f1000r.es/1xl ]   
Published: 02 Oct 2013   
Shen X, Rönnegård L.   
F1000Research 2:200     

RESEARCH ARTICLE
Isoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain [ http://f1000research.com/articles/2-204/v1 ] [v1; ref status: indexed, http://f1000r.es/1mg ]    
Published: 04 Oct 2013    
Kaddoum L, Panayotis N, Mazarguil H et al.     
F1000Research 2:204   


~~~~~~~~~~
 APC Waiver until December 31st
~~~~~~~~~~

Until December 31st, we're waiving the article processing charge on your first ecology paper [ http://f1000research.com/ecology2013?code=ECOL20  ], software paper [ http://f1000research.com/software2013?code=SOFT13PM ], or medical case report [ http://f1000research.com/case-reports2013?code=CASE19 ]. Click the relevant link to retrieve your waiver code.

---------------------------------------------
 Submit now to F1000Research          
 >> http://f1000research.com/author/submit        
----------------------------------------------

    
   F1000Trials                     
==================

A comprehensive listing [ http://f1000.com/trials ] of clinical trial articles reviewed by the F1000 Faculty, with the most important tagged as recommended.

Below is a taster of F1000Trials content. To read, please sign-in [ http://f1000.com/trials/signin ] or register for free [ http://f1000.com/trials/register ]:  

Knife vs. Kegels    
[ http://f1000.com/trials/718114072?key=M2a2G68jjsMFWXY ]   
An RCT suggests that surgery should be offered over physiotherapy (pelvic floor exercises) as first-line treatment for stress urinary incontinence.   
Labrie J, Berghmans BLCM, Fischer K et al.    
N Engl J Med. 2013 Sep 19; 369:1124-33

A weighty issue      
[ http://f1000.com/trials/718118375?key=1Qmb7chqnpQMPKP ]   
It might seem obvious, but an RCT confirms that exercise and diet plans help those with knee osteoarthritis lose weight and hence lighten the load on the joints.  
Messier SP, Mihalko SL, Legault C et al.     
JAMA. 2013 Sep 25; 310:1263-73

A topical subject for keratitis    
[ http://f1000.com/trials/13357382?key=gtSMlyDfzD35Xve ]   
Is there clinical benefit in using topical corticosteroids as adjunctive therapy in the treatment of bacterial keratitis?
Srinivasan M, Mascarenhas J, Rajaraman R et al.    
Arch Ophthalmol. 2012 Feb; 130(2):143-50   

    
    
    F1000Posters                 
======================
 
Open Repository [ http://f1000.com/posters ] for posters and slide presentations; completely free to view and submit. Below are a few selections:

* NEUROSCIENCE *    
 
Shifts of attention in video game players and non-players    
[ http://f1000.com/posters/browse/summary/1094619 ]   
Mack D, Wiesmann H, Ilg U.   
F1000Posters 2013, 4:1330   

* SCIENCE COMMUNICATION *   

The academic impact of research: current and the future citation trends in developing countries    
[ http://f1000.com/posters/browse/summary/1094613 ]   
Ebrahim NA.   
F1000Posters 2013, 4:1322  

* ANESTHESIOLOGY & PAIN MANAGEMENT *

An exploration of religious faith and the management of pain among older people   
[ http://f1000.com/posters/browse/summary/1094646 ]    
Edwards J, Briggs M, Atkin K et al.    
F1000Posters 2013, 4:1357   

----------------------------------------------
 Deposit now        
 >> http://f1000.com/posters/fordepositors      
---------------------------------------------- 
 
  
----------------------

 * F1000Tips *

Follow @F1000Tips on Twitter [ http://twitter.com/f1000tips ] for tips, tricks, and customer support for all Faculty of 1000 service:

@F1000 | https://twitter.com/f1000   
@F1000Trials | http://twitter.com/f1000trials  
@F1000Research | http://twitter.com/f1000research   
@F1000Posters | http://twitter.com/f1000posters 
  
---------------------- 
 
-----------------------------------------------------   

In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).

You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may unsubscribe [ http://www.f1000.com/unsubscribe/email?email=jeeproject@yahoo.com&emailAlertType=MONTHLY_UPDATES ] at any time. For further information or enquiries please contact Customer Services at info@f1000.com [ mailto:info@f1000.com ].

Faculty of 1000 Ltd | Science Navigation Group
Registered in England and Wales with Company Number 3739756
Middlesex House, 34-42 Cleveland Street | London, W1T 4LB | United Kingdom

--2385251807521937
Content-Type: text/html; charset=iso-8859-15
Content-Transfer-Encoding: 8bit

<html><!--"Multipart/Alternative MIME" format-->
<style type="text/css">
	.footer a, .footer a:visited { color:#CCCCCC;}
	blockquote .hide-forwarded {display: none !important;}
</style>
	<body leftmargin="0" marginwidth="0" topmargin="0" marginheight="0" offset="0">
		<table width="100%" border="0" cellpadding="0" cellspacing="0">
			<tr>
				<td>
					<table width="640" align="center" border="0" cellpadding="0" cellspacing="0" >
						<!-- BEGIN Header -->
							<tr>
							<td width="5" colspan="5" style="background-color: #FFF">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5">
							</td>
						</tr>
						<tr>
							<td colspan="5" style="text-align:center;color:#666;font-family:arial,sans-serif;font-size:11px;">
								<strong style="font-weight:bold;">To ensure you receive F1000 emails, add <a style="color:#CB2D2D; text-decoration: none;" href="mailto:info@updates.f1000.com">info@updates.f1000.com</a> to your safelist.<br>If this email is not displaying properly, please <a style="color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HM?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWY_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF7">view in your usual browser</a>.</strong>							</td>
					  </tr>
						<tr>
							<td width="5" colspan="5" style="background-color: #FFF">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5">
							</td>
						</tr>
						<tr>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>	
							<td colspan="3">
								<!-- BEGIN 468x60 ad slot -->
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" height="1"></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="15" /></td>
									</tr>
									<tr>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
										<td width="468" height="60">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWYPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF4"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/13-1212_V3_Banner_468x60.jpg" style="display:block;"width="468" height="60" border="0" alt="" title="Top Banner"/></a>
										</td>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
									</tr>
									<tr>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
										<td  width="468" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="8" /></td>
									</tr>
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>	
								</table>
								<!-- END 468x60 ad slot -->
							</td>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>
						</tr>

						<tr>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>
							<td colspan="3">
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>
									<!-- BEGIN Network Bar -->
									<tr>
										<td colspan="3" width="100%">
											<table style="background-color: #222222;" border="0" cellpadding="0" cellspacing="0" width="640">
												<tr>
													<td width="10" height="30">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="10" height="1" style="display:block;">
													</td>
													<td width="80">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWYfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF5" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000prime.gif" width="80" height="30" border="0" title="Network Bar - Prime">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="76">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWZvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF-" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000trials.gif" width="76" height="30" border="0" title="Network Bar - Trials">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="102">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWZ_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF_" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000research.gif" width="102" height="30" border="0" title="Network Bar - Research">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="91">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWZPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF8" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000posters.gif" width="91" height="30" border="0" title="Network Bar - Posters">
														</a>
													</td>
													<td width="176">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
												</tr>
											</table>
										</td>
									</tr>
									<!-- END Network Bar -->
									<!-- BEGIN Header Image -->
									<tr>
										<td colspan="3" width="640" height="70">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWZfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlF9"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/monthly_update_email_header_grey.gif" border="0" width="640" height="70" title="F1000 Monthly Update Email Header" alt="F1000 Monthly Update Email Header" style="display:block;"/></a>
										</td>
									</tr>
									<!-- END Header Image -->
								</table>
							</td>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
						</tr>
						<!-- END Header -->
						<!-- BEGIN Content -->
						<tr>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
							<!-- BEGIN Left Content Column -->
							<td valign="top">
								<table border="0" cellpadding="0" cellspacing="0" width="478">
									<tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="15"></td>
									</tr>
									<!-- BEGIN Date and Intro -->
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:18px;">
											December 2013
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                     <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:14px;">
                                        <table width="440" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td valign="center" width="100" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:14px;"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/F1000xmas_tree.jpg" title="The F1000 Christmas Tree" alt="The F1000 Christmas Tree" width="100" height="100"></td>
    <td width="340" valign="center" style="padding: 0 0 0 20; font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:18px;">Season's greetings and best wishes<br>for the New Year from everybody at<br>Faculty of 1000!</td>
    
  </tr>
</table>
</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:14px;">
											Highly influential scientists amongst F1000 Faculty
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:normal; color:#383838;font-family:'arial bold',sans-serif;font-size:12px;">Using  citation data collected from 1996-2011, authors writing in the<em> European Journal  of Investigation</em> last month published a list of 539 influential biomedical  researchers, of which <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWevcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKC" style="font-weight:bold; color:#CB2D2D; text-decoration: none;" title="Top News - FM among highly influencial researchers">59 are F1000Prime Faculty Members</a>.</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    <tr>
										<td width="20" colspan="7" style="background-color: #FFF; "><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:14px;">F1000Prime partnership in bioinformatics</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:normal; color:#383838;font-family:'arial bold',sans-serif;font-size:12px;">Members of the International Society for Computational Biology can now <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWe_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKD" style="font-weight:bold; color:#CB2D2D; text-decoration: none;" title="Top News - ISCB">receive full access to F1000Prime until 30 April 2014</a> as part of their society membership. And -- a list of the latest recommended articles in F1000Prime's Bioinformatics and Computational Biology Faculty <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWePcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKA" style="font-weight:bold; color:#CB2D2D; text-decoration: none;" title="Top News - Mendeley">is freely available in Mendeley</a>.</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    <tr>
										<td width="20" colspan="7" style="background-color: #FFF; "><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<!-- END Date and Intro --> 
									<tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
									</tr>
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="220">
												<!-- BEGIN Prime -->
												<tr>
													<td style="background-color: #CB2D2D">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWefcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKB">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_prime.jpg" alt="Prime - Logo"width="220" height="75"style="display:block;" title="Prime - Logo" border="0">
														</a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
                                                    
                                                    
														<strong><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWfvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKG" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;" title="Prime - Link to HP">1,328 recommendations</a> added in the past month. Below is a selection:</strong>
												  </td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWf_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKH" title="Prime - Eval 1">Back to full potential</a><br />
														This paper provides a loophole  to the stochastic nature of reprogramming, allowing somatic cells to be  reverted back into pluripotent stem cells.<br>
Rais Y, Zviran A, Geula S <em>et al</em>.
<br><em>Nature</em>. 2013 Oct 3; 502:65-70</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWfPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKE" title="Prime - Eval 2">Decoding asthma</a><br />
														This study on asthma  polymorphisms demonstrates a broad approach with which to bridge the gap  between genetic association at the population level and molecular cell  mechanisms.<br>														Ho JE, Chen WY, Chen MH <em>et al</em>.<br>
														<em>J Clin Invest</em>. 2013 Oct 1; 123:4208-18</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWffcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKF" title="Prime - Eval 3">Significant stats</a><br />
														Too often scientists try to find a statistical significance test "validating" their hypothesis after the experiment, which may be a reason why so many studies are irreproducible.
                                                        <br>
                                                       Johnson VE.
                                                        <em>Proc Natl Acad Sci U S A</em>. 2013; 110:19313-7</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:14px;">
														<strong style="font-weight:bold;">F1000Prime Reports</strong>
													</td>
												</tr>
												<tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                <tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><strong><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWcvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKK" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;" title="Prime - Reports: Link">Open-access review journal</a>, reporting on the hottest topics.</strong></td>
												</tr>
                                                
                                                <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												  <tr>
													<td width="220" height="103">
														<a style="font-weight:bold; color:#CB2D2D;text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWc_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKL"><img src="http://f1000.com/prime/reports/b/5/51/feature-thumbnail.jpg" alt="F1000Prime Reports" width="220" style="display:block;" title="Prime - Reports: Thumbnail" border="0"/></a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D;text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWcPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKI" title="Prime - Reports: Article">New and alternative approaches to tackling antibiotic resistance</a><br />
														Multi-drug-resistant bacteria are fast overcoming our current arsenal of antibiotics, thanks to our complacency, but recent advances in thwarting their resistance mechanisms give us cause for hope.<br />
														<em>F1000Prime Report</em> by Theriault  N and <a style="color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWcfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKJ" title="Prime - Reports: FM">Tillotson GS</a>.
													<br>
													<em>F1000Prime Rep</em> 2013, <strong>5</strong>:51<br><br>
                                                    <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWdvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKO" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;" title="Prime - All reports">See all recent <em>F1000Prime Reports</em>.</a></td>
											  	</tr>
												<tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<!-- END Prime -->
											</table>
										</td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Research -->
												<tr>
													<td style="background-color: #CB622D">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWd_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKP">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_research.jpg" alt="Research - Logo" title="Research - Logo"width="220" height="75" style="display:block;" border="0">
														</a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<strong>Our innovative <a style="font-weight:bold; color:#CB622D; text-decoration: none;"href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWdPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKM">open access journal</a> offering rapid publication, open peer review and open data.<br>
                                                  <br>
                                                  Below is a selection of our latest peer reviewed articles:</strong></td>
										    </tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">RESEARCH ARTICLE</span><br />
												  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWdfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKN">Homologous electron transport components fail to increase fatty acid hydroxylation in transgenic Arabidopsis thaliana</a> [v2; ref status: indexed, <a  style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWCvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKS">http://f1000r.es/2a3</a>]<br />
									          			Latest Published: 13 Nov 2013<br />
									          			Wayne LL, Browse J.<br>
									          			<em>F1000Research</em> <strong>2</strong>:203</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><span style="font-family: arial, sans-serif; color: #999">CORRESPONDENCE</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWC_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKT">Issues with data transformation in genome-wide association studies for phenotypic variability</a> [v1; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWCPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKQ">http://f1000r.es/1xl</a>]<br />
										      		    Published: 02 Oct 2013<br />
										      		    Shen X, R&ouml;nneg&aring;rd L.<br />
														<em>F1000Research</em> <strong>2:</strong>200</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999;"> RESEARCH ARTICLE</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWCfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKR">Isoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain</a> [v1; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWDvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKW">http://f1000r.es/1mg</a>]<br />
														Published: 04 Oct 2013<br />
														Kaddoum L, Panayotis N, <br>Mazarguil H <em>et al</em>.<br>
												        <em>F1000Research</em> <strong>2</strong>:204
												    </td>
												</tr>
												
												
                                                
                                                
                                                
                                                <tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td bgcolor="#CB622D" style="color:#FFFFFF;font-family:arial,sans-serif;font-size:12px; padding: 5px"><strong>APC Waiver until December 31st</strong></td>
											  </tr>
                                              <tr>
													<td style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
											  </tr>
                                              <tr>
													<td style="background-color: #FFF"></td>
											  </tr>
                                              
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Until December 31st,  we're waiving the article processing charge on your first <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWLvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK2" style="text-decoration:none; color:#CB622D;">ecology paper</a>, <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWD_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKX" style="text-decoration:none; color:#CB622D;">software paper</a>,  or <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWDPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKU" style="text-decoration:none; color:#CB622D;">medical case  report</a>. Click the relevant link to retrieve your waiver code.
                                                 </td>
											  </tr>
												<tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="15"></td>
												</tr>
                                                <tr>
                                                <td align="center"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWDfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKV"><img src="http://webr.emv2.com/faculty1000/flying-man_eToC_img.gif" width="151" height="126"></a></td>
                                                </tr>
                                                <tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
                                                <tr>
													<td width="30" colspan="3" style="background-color: #FFF"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWAvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKa" style="text-decoration:none; color:#CB622D;"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Submit-Now.gif" alt="Submit Now" width="136" height="27" border="0" style="display:block;" title="Submit your article" heigt="30"/>	</td>
												</tr>
                                                
                                                <tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
												<!-- END Research -->
											</table>
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td height="1" colspan="7" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Trials -->
																								
                                                <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
<tr>
					  <td colspan="3" style="background-color: #2d8acb"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWA_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKb"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/header_trials.jpg" border="0" title="Trials - Logo" style="display:block;"width="220" height="75"></a></td>
							    </tr>
                                 <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
                                <tr>
                                  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style=" color:#2D8ACB; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWAPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKY" title="Trials - HP (Link)"><strong>A comprehensive listing</strong></a><strong> of clinical trial articles reviewed by the F1000  Faculty, with the most important tagged as recommended.</strong></td>
											  </tr>
                                
                                                <tr>
                                                  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
                                                
                                                
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Below is a taster of F1000Trials content. To read, please <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWAfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKZ" style="font-weight:bold; color:#2D8ACB; text-decoration:none" title="Trials - Sign-in">sign-in</a> or <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWBvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKe" style="font-weight:bold; color:#2D8ACB; text-decoration:none" title="Trials - Register">register for free</a>:</td>
												</tr>
												<tr>
												  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
                                              <tr>
                                                <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWB_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKf" title="Trials - Eval 1">Knife vs. Kegels</a><br />
                                                  An RCT suggests that surgery should be offered over physiotherapy (pelvic  floor exercises) as first-line treatment for stress urinary incontinence.<br>
                                                Labrie J, Berghmans BLCM, Fischer K <em>et al</em>. <em>N Engl J Med</em>. 2013 Sep 19;  369:1124-33</td>
											  </tr>
                                              <tr>
                                                <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
                                              
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWBPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKc" title="Trials - Eval 2">A weighty issue</a><br />
												    It might seem obvious, but an RCT confirms that exercise and diet plans  help those  with knee osteoarthritis lose weight and hence lighten the load on the joints.<br>
                                                  Messier SP, Mihalko SL, Legault C <em>et al</em>. <br><em>JAMA</em>. 2013 Sep 25; 310:1263-73</td>
											  </tr>
                                              <tr>
                                                <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWBfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKd" title="Trials - Eval 3">A topical subject for keratitis</a><br>
												    Is  there clinical benefit in using topical corticosteroids as adjunctive therapy  in the treatment of bacterial keratitis?<br>
												    Srinivasan M, Mascarenhas J, Rajaraman R <em>et al</em>. 
                                                  <em>Arch Ophthalmol</em>. 2012 Feb; 130(2):143-50</td>
											  </tr>
                                              
                                              
												<tr>
												  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
												<!-- END Trials -->
											</table>
										</td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Posters -->
												<tr>
													<td width="80" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="10"></td>
												</tr>
													<tr>
													<td colspan="3" style="background-color: #733380">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWGvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKi">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_posters.jpg" border="0" style="display:block;"width="220" height="75">														</a>													</td>
												</tr>
												<tr>
													<td width="80" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<strong>	<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWG_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKj" style="text-decoration:none; color:#733380;" title="Poster - HP">Open Repository</a> for posters and slide presentations; completely free to view and submit.  Below is a selection:</strong>													</td>
											  </tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="30"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999; font-family:arial,sans-serif;">NEUROSCIENCE</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWGPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKg"><img src="http://cdn.f1000.com/posters/thumbnails/257761086" border="0" width="80" heigt="122" title="Poster 1 (IMG)"alt="poster_1" style="display:block;"/></a> </td>
													<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td width="132" valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a  style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWGfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKh" title="Poster 1 (Link)">Shifts of attention in video game players and non-players</a><br>
                                                    Mack D, Wiesmann H, Ilg U.<br>
F1000Posters 2013,<br><strong>4</strong>:1330
                                                    </td>
												</tr>
												
                                                
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">SCIENCE COMMUNICATION</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWHvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKm"><img src="http://cdn.f1000.com/posters/thumbnails/257733384" alt="Poster 2" width="80" height="60" style="display:block;" title="Poster 2 (IMG)" border="0" heigt="113"/></a>													</td>
														<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWH_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKn" title="Poster 2 (Link)">The academic impact of research: current and the future citation trends in developing countries</a></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><span style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Ebrahim NA.<br>
F1000Posters 2013, <strong>4</strong>:1322</span></td>
												</tr>
                                                
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												 <tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">ANESTHESIOLOGY & PAIN MANAGEMENT</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWHPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKk"><img src="http://cdn.f1000.com/posters/thumbnails/257825627" alt="Poster 2" width="80" height="124" style="display:block;" title="Poster 3 (IMG)" border="0" heigt="114"/></a>													</td>
														<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWHfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKl" title="Poster 3 (Link)">An exploration of religious faith and the management of pain among older people</a><br>
                                                    Edwards  J, Briggs M, Atkin K <em>et al</em>.<br>
F1000Posters 2013,<br><strong>4</strong>:1357</td>
												</tr>
												
                                                <tr>
													<td height="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" heigt="20">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWEvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKq">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Deposit-Now.gif" border="0" width="136" heigt="27" title="Deposit Now" alt="Deposit a Poster" style="display:block;"/>														</a>													</td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<!-- END Posters -->
											</table>
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>	
								</table>
							</td>
							<!-- END Left Content Column -->
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
							<!-- BEGIN Right Content Column -->
							<td valign="top">
								<table border="0" cellpadding="0" cellspacing="0" width="159">
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" heigt="22">
											<!-- BEGIN Share Widget -->
											<a href="http://p4trc.emv2.com/HSL?lang=us&a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLJ3zyvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMldJ"><img src="http://p4trc.emv2.com/dispatcher/images/share/swmn01a.gif" border="0" align="absmiddle" title="Share this email"></a>
											<!-- END Share Widget -->
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<!-- BEGIN News Section -->
									
                                
                                    
                                    

                                    <tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="font-weight:bold;color:#383838;font-family:arial,sans-serif;font-size:14px;">F1000Prime: Live online demo</td>
								  	  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="color:#383838;font-family:arial,sans-serif;font-size:11px;">Get the most out of F1000Prime - attend a live online demonstration.<br><br>
                                        Please choose one of the following time zones:<br><br>
                                        <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWE_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKr"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/US-Demo.gif" alt="US Demo" width="136" height="27" border="0" style="display:block;" title="US Demo" /></a><br><br>
                                        <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWEPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKo"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/EU-Asia-Demo.gif" alt="EU & Asia Demo" width="136" height="27" border="0" style="display:block;" title="EU & Asia Demo" /></a>
                                        
                                      </td>
									  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
                                    
									
									
									<tr>
										<td colspan="4" heigt="600">
										    <!-- begin ad tag 160x600  ad slot size -->
											 <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWEfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKp"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/13-1212_V3_Banner_160x600V2.jpg" style="display:block;"width="160" height="600" border="0" alt="" title="Skyscraper"/></a>
											<!-- End ad tag 160x600  ad slot size -->
										</td>
									</tr>
									<tr>
										<td colspan="4" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
									</tr>
                                    
                                    
                                     <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
				          <!-- END News Section -->
									
									 <tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="font-weight:bold;color:#383838;font-family:arial,sans-serif;font-size:14px;"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWFvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKu"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/F1000tips.gif" alt="F1000Tips" border="0" style="display:block;" width="139" height="139"></a></td>
								  	  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="color:#383838;font-family:arial,sans-serif;font-size:11px;">Follow <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWF_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKv" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">@F1000Tips</a> on  Twitter for tips, tricks, and customer support for all Faculty of 1000 services:<br><br>
                                      <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWFPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKs" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">@F1000</a>, <br><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWFfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKt" style="font-weight:bold; color:#2d8acb; text-decoration: none;">@F1000Trials</a>, <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWKvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKy" style="font-weight:bold; color:#CB622D; text-decoration: none;">@F1000Research</a>, <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWK_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKz" style="font-weight:bold; color:#733380; text-decoration: none;">@F1000Posters</a></td>
									  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
                                    
				          <!-- END of twitter section -->
                                    
								
                                    
								</table>
                                
                                
                                
							</td>
							<!-- END Right Content Column -->
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
						</tr>
						<!-- END Content -->
						<!-- BEGIN Footer -->
						<tr>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
							<td colspan="3">
								<!-- BEGIN 468x60 ad slot -->
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" height="1"></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="15" /></td>
									</tr>
									<tr>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
										<td width="468" height="60">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWKPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKw"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/13-1212_V3_Banner_468x60.jpg" style="display:block;"width="468" height="60" border="0" alt="" title="Bottom Banner"/></a>
										</td>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
									</tr>
									<tr>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
										<td  width="468" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="8" /></td>
									</tr>
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>	
								</table>
								<!-- END 468x60 ad slot -->
							</td>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
						</tr>
						<!-- END Footer -->
						<!-- BEGIN Footer -->
						<tr>
							<td colspan="5">
								<table border="0" cellpadding="0" cellspacing="10" style="background: #222222; border:1px solid #ccc;" width="100%">
									<tr>
										<td style="color:#CCCCCC;font-family:arial,sans-serif;font-size:11px;">
											In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).<br><br>
											<span class="hide-forwarded">You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may <a href="http://p4trc.emv2.com/HP?a=ENX7CqkWrP9-8SA9MKJrvpnnGHxKLgMWKfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKx" style="color:#CCCCCC;text-decoration:none;" target="_blank"><font color="#CCCCCC" font-size="2" face="arial,sans-serif"><b>unsubscribe</b></font></a> at any time. </span>For further information or enquiries please contact Customer Services at <a href="mailto:info@f1000.com" style="color:#CCCCCC;text-decoration:none;"><font color="#CCCCCC" font-size="2" face="arial,sans-serif"><b>info@f1000.com</b></font></a>.<br /><br />
											Faculty of 1000 Ltd &#124; Science Navigation Group<br>
											<b>Registered in England and Wales with Company Number 3739756</b><br>
											Middlesex House, 34-42 Cleveland Street &#124; London, W1T 4LB &#124; United Kingdom
										</td>
									</tr>
								</table>
							</td>
						</tr>
						<!-- END Footer -->
					</table>
				</td>
			</tr>
		</table>
	<img src="http://p4trc.emv2.com/HO?DdX7CqkWrP9-8SA9MOPv4OvnGHxKLLmWqQjtS5kGWGBQKx4.gif" border="0" alt="" width="1" height="1" /></body>
</html>
--2385251807521937--

